Asahi Kasei Therapeutics Corporation

Clinical trials sponsored by Asahi Kasei Therapeutics Corporation, explained in plain language.

Now part of Asahi Kasei Corporation 3407 TOKYO

Pharmaceutical arm of a diversified Japanese conglomerate, developing therapies in areas like neurology and inflammation.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

New blood test may help Fine-Tune diabetes treatment faster

Knowledge-focused Completed

This study looked at whether using a blood marker called glycated albumin (GA) to guide diabetes treatment works better than the usual HbA1c test. 200 adults newly diagnosed with type 2 diabetes were split into two groups: one where doctors used GA levels to adjust medication, an…

Sponsor: Asahi Kasei Therapeutics Corporation • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:01 UTC

Asahi Kasei Therapeutics Corporation

New blood test may help Fine-Tune diabetes treatment faster